Correlation Between Savara and Protagenic Therapeutics
Can any of the company-specific risk be diversified away by investing in both Savara and Protagenic Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Savara and Protagenic Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Savara Inc and Protagenic Therapeutics, you can compare the effects of market volatilities on Savara and Protagenic Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Savara with a short position of Protagenic Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Savara and Protagenic Therapeutics.
Diversification Opportunities for Savara and Protagenic Therapeutics
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Savara and Protagenic is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Savara Inc and Protagenic Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protagenic Therapeutics and Savara is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Savara Inc are associated (or correlated) with Protagenic Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protagenic Therapeutics has no effect on the direction of Savara i.e., Savara and Protagenic Therapeutics go up and down completely randomly.
Pair Corralation between Savara and Protagenic Therapeutics
Given the investment horizon of 90 days Savara Inc is expected to under-perform the Protagenic Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Savara Inc is 2.13 times less risky than Protagenic Therapeutics. The stock trades about 0.0 of its potential returns per unit of risk. The Protagenic Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 87.00 in Protagenic Therapeutics on September 2, 2024 and sell it today you would lose (28.00) from holding Protagenic Therapeutics or give up 32.18% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Savara Inc vs. Protagenic Therapeutics
Performance |
| Timeline |
| Savara Inc |
| Protagenic Therapeutics |
Savara and Protagenic Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Savara and Protagenic Therapeutics
The main advantage of trading using opposite Savara and Protagenic Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Savara position performs unexpectedly, Protagenic Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protagenic Therapeutics will offset losses from the drop in Protagenic Therapeutics' long position.| Savara vs. Stoke Therapeutics | Savara vs. Edgewise Therapeutics | Savara vs. Crinetics Pharmaceuticals | Savara vs. Dyne Therapeutics |
| Protagenic Therapeutics vs. Tff Pharmaceuticals | Protagenic Therapeutics vs. Eliem Therapeutics | Protagenic Therapeutics vs. Inhibrx | Protagenic Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |